trending Market Intelligence /marketintelligence/en/news-insights/trending/okmftifvuvel-whqbfiu5g2 content esgSubNav
In This List

PAVmed to raise $10.4M in rights offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


PAVmed to raise $10.4M in rights offering

PAVmed Inc. expects to raise about $10.4 million in gross proceeds from an oversubscribed rights offering that expired June 7.

The New York-based medical device company said it has accepted valid subscriptions including up to 9 million units of the total oversubscribed amount.

Each right entitles the holder to buy one unit at $1.15 apiece, with each unit consisting of 1 common share and 1 series Z warrant to buy 1 common share exercisable at $1.60 each.

The units will be immediately split into their underlying securities, and the common stock and warrants will be immediately tradeable upon their issuance.

PAVmed expects the rights offering to close on June 12, subject to customary closing conditions.

Maxim Group LLC and Dawson James Securities Inc. are serving as dealer-managers in the offering.